GetTopicDetailResponse(id=29e8125644a6, topicName=匹妥布替尼, introduction=, content=B細胞腫瘤 匹妥布替尼, image=null, comments=0, allHits=175, url=null, type=0, isShow=1, status=1, isAdmin=null, adminId=5395722, adminEncryptionId=cade5395722, adminName=梅斯管理員, createdBy=cade5395722, createdName=梅斯管理員, createdAvatar=, createdTime=Mon Mar 31 16:14:39 CST 2025, time=2025-03-31, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=503082, tagList=[TagDto(tagId=503082, tagName=匹妥布替尼)], ipAttribution=, topicAdmin=0, lengthMark=0)
[GetTopicListResponse(id=2268598, encodeId=1e1a226859883, content=<a href='/topic/show?id=50e0485323' target=_blank style='color:#2F92EE;'>#CLL/SLL#</a> <a href='/topic/show?id=29e8125644a6' target=_blank style='color:#2F92EE;'>#匹妥布替尼#</a>, objectTitle=【JCO】匹妥布替尼對比BR或R+Idelalisib治療共價BTKi經(jīng)治CLL/SLL的3期研究結(jié)果, objectType=article, longId=881560, objectId=67a9881560bb, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20250219/1739953344506_8538692.jpg, objectUrl=/article/show_article.do?id=67a9881560bb, replyNumber=0, likeNumber=37, createdTime=2025-06-09, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=67a9881560bb, moduleTitle=【JCO】匹妥布替尼對比BR或R+Idelalisib治療共價BTKi經(jīng)治CLL/SLL的3期研究結(jié)果, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=67a9881560bb)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2258532, encodeId=ebf62258532f8, content=<a href='/topic/show?id=1dc23854e7' target=_blank style='color:#2F92EE;'>#B細胞腫瘤#</a> <a href='/topic/show?id=29e8125644a6' target=_blank style='color:#2F92EE;'>#匹妥布替尼#</a>, objectTitle=匹妥布替尼治療復發(fā)難治B細胞腫瘤的中國橋接研究結(jié)果, objectType=article, longId=869862, objectId=4ef0869862b2, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20220801/1659342224826_8252897.webp, objectUrl=/article/show_article.do?id=4ef0869862b2, replyNumber=0, likeNumber=32, createdTime=2025-03-31, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4ef0869862b2, moduleTitle=匹妥布替尼治療復發(fā)難治B細胞腫瘤的中國橋接研究結(jié)果, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=4ef0869862b2)], followStatus=false, userIsMember=false, type=null, lengthMark=0)]
梅斯管理員
2025-03-31
